Supplemental material
Biomarkers
Volume 26, 2021 - Issue 4
Open access
1,665
Views
0
CrossRef citations to date
0
Altmetric
Original Articles
Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer
Reham Helwaa K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway;b Department of Oncology, Haukeland University Hospital, Bergen, NorwayView further author information
, Liv B. Gansmoa K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway;b Department of Oncology, Haukeland University Hospital, Bergen, NorwayView further author information
, Merete Bjørnslettc Department of Molecular Oncology, Oslo University Hospital Radium Hospitalet, Oslo, Norway;d Institute for Cancer Research, University of Oslo, Oslo, NorwayView further author information
, Mari Kyllesø Hallee Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway;f Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, NorwayView further author information
, Henrica M. J. Wernere Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway;f Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, NorwayView further author information
, Pål Romundstadg Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NorwayView further author information
, Kristian Hveemh K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NorwayView further author information
, Lars Vatteng Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NorwayView further author information
, Anne Dørumi Department of Gynecologic Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, NorwayView further author information
, Per E. Lønninga K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway;b Department of Oncology, Haukeland University Hospital, Bergen, NorwayView further author information
& Stian Knappskoga K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway;b Department of Oncology, Haukeland University Hospital, Bergen, NorwayCorrespondence[email protected]
https://orcid.org/0000-0002-4153-1655View further author information
show allhttps://orcid.org/0000-0002-4153-1655View further author information
Pages 302-308
|
Received 22 Aug 2020, Accepted 07 Feb 2021, Published online: 28 Feb 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.